Nanexa AB
Develops long-acting injectables using a proprietary nanotechnology drug delivery system.
NANEXA | ST
Overview
Corporate Details
- ISIN(s):
- SE0007074166 (+2 more)
- LEI:
- 549300J5L2ECZTLID491
- Country:
- Sweden
- Address:
- Virdings Allé 2, 754 50 Uppsala
- Website:
- https://nanexa.com/
- Sector:
- Manufacturing
Description
Nanexa AB is a pharmaceutical development company specializing in Long-Acting Injectables (LAIs). The company's core is its proprietary drug delivery system, PharmaShell®, a nanotechnology platform that utilizes Atomic Layer Deposition (ALD) to coat drug particles. This technology enables the precise and controlled long-term release of medications, facilitating the development of a new generation of drug products, including 'super generics'. Nanexa's focus is on creating injectable treatments with less frequent administration, such as monthly injections, for therapeutic areas including type 2 diabetes, obesity, cancers, and psychiatric disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Nanexa AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nanexa AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nanexa AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
